8-K: eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

SECMay 9, 2024 16:15 ET

10-Q: Q1 2024 Earnings Report

SECMay 9, 2024 16:10 ET · Announcements

Express News | Trading Halt: Halt Status Updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times

Moomoo 24/7Apr 4, 2024 09:00 ET

EFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined With Pembrolizumab in Non-Small Cell Lung Cancer

Yahoo FinanceApr 4, 2024 08:30 ET

Express News | Trading Halt: Halted at 8:25:00 A.m. ET - Trading Halt: Halt News Pending

Moomoo 24/7Apr 4, 2024 08:25 ET

EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 8-K: eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

SECMar 25, 2024 16:15 ET